Profile
Jayakrishna Ambati is the founder of Inflammasome Therapeutics, Inc. which was founded in 2016, where he holds the title of Director.
He is currently working as Director & VP-Advanced Ocular Design at iVeena Delivery Systems, Inc.
Jayakrishna Ambati active positions
Companies | Position | Start |
---|---|---|
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Director/Board Member | - |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Founder | 31/12/2015 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Stock Market
- Insiders
- Jayakrishna Ambati